L-Adrenalin Fresenius may be available in the countries listed below.
Epinephrine is reported as an ingredient of L-Adrenalin Fresenius in the following countries:
International Drug Name Search
bue-PIV-a-kane LYE-poh-some
In the U.S.
Available Dosage Forms:
Therapeutic Class: Anesthetic, Local
Chemical Class: Amino Amide
Bupivacaine liposome injection is used to relieve pain after surgery. It belongs to the family of medicines called local anesthetics. bupivacaine liposome prevents pain by blocking the signals at the nerve endings
bupivacaine liposome is to be given only by or under the direct supervision of a doctor.
In deciding to use a medicine, the risks of taking the medicine must be weighed against the good it will do. This is a decision you and your doctor will make. For bupivacaine liposome, the following should be considered:
Tell your doctor if you have ever had any unusual or allergic reaction to bupivacaine liposome or any other medicines. Also tell your health care professional if you have any other types of allergies, such as to foods, dyes, preservatives, or animals. For non-prescription products, read the label or package ingredients carefully.
Appropriate studies have not been performed on the relationship of age to the effects of bupivacaine liposome injection in the pediatric population. Safety and efficacy have not been established.
Appropriate studies performed to date have not demonstrated geriatric-specific problems that would limit the usefulness of bupivacaine liposome injection in the elderly. However, elderly patients are more likely to have kidney or liver problems, which may require caution for patients receiving bupivacaine liposome injection.
| Pregnancy Category | Explanation | |
|---|---|---|
| All Trimesters | C | Animal studies have shown an adverse effect and there are no adequate studies in pregnant women OR no animal studies have been conducted and there are no adequate studies in pregnant women. |
Studies in women suggest that this medication poses minimal risk to the infant when used during breastfeeding.
Although certain medicines should not be used together at all, in other cases two different medicines may be used together even if an interaction might occur. In these cases, your doctor may want to change the dose, or other precautions may be necessary. Tell your healthcare professional if you are taking any other prescription or nonprescription (over-the-counter [OTC]) medicine.
Certain medicines should not be used at or around the time of eating food or eating certain types of food since interactions may occur. Using alcohol or tobacco with certain medicines may also cause interactions to occur. Discuss with your healthcare professional the use of your medicine with food, alcohol, or tobacco.
The presence of other medical problems may affect the use of bupivacaine liposome. Make sure you tell your doctor if you have any other medical problems, especially:
A nurse or other trained health professional will give you bupivacaine liposome in a hospital. bupivacaine liposome is given through a needle injected into the surgical site (such as big toe).
bupivacaine liposome should cause numbness only to the area where it is injected. You may experience temporary loss of sensation or motor skills to the area injected. This type of numbing procedure is called local anesthesia. It is not meant to cause you to fall asleep or become unconscious.
Bupivacaine liposome injection (Exparel™) works differently with other formulations of bupivacaine, even at the same dose (number of milligrams). Do not convert or change the dosing from any other formulations of bupivacaine to Exparel™.
Your doctor will check you closely while you are receiving bupivacaine liposome. This is to check for any problems or unwanted effects that may be caused by bupivacaine liposome.
Tell your doctor or nurse right away if you have the following symptoms after receiving bupivacaine liposome: anxiety, blurred vision, depression, drowsiness, lightheadedness, nausea or vomiting, numbness and tingling of the mouth and lips, restlessness, ringing in the ears, speech problems, or tremors.
bupivacaine liposome may cause serious allergic reactions, including anaphylaxis. Anaphylaxis can be life-threatening and requires immediate medical attention. Call your doctor right away if you have a rash; itching; fever; increased sweating; lightheadedness or fainting; trouble breathing; trouble swallowing; or any swelling of your hands, face, mouth, or throat after receiving bupivacaine liposome.
Along with its needed effects, a medicine may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.
Check with your doctor or nurse immediately if any of the following side effects occur:
Some side effects may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:
Other side effects not listed may also occur in some patients. If you notice any other effects, check with your healthcare professional.
Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088.
The information contained in the Thomson Reuters Micromedex products as delivered by Drugs.com is intended as an educational aid only. It is not intended as medical advice for individual conditions or treatment. It is not a substitute for a medical exam, nor does it replace the need for services provided by medical professionals. Talk to your doctor, nurse or pharmacist before taking any prescription or over the counter drugs (including any herbal medicines or supplements) or following any treatment or regimen. Only your doctor, nurse, or pharmacist can provide you with advice on what is safe and effective for you.
The use of the Thomson Reuters Healthcare products is at your sole risk. These products are provided "AS IS" and "as available" for use, without warranties of any kind, either express or implied. Thomson Reuters Healthcare and Drugs.com make no representation or warranty as to the accuracy, reliability, timeliness, usefulness or completeness of any of the information contained in the products. Additionally, THOMSON REUTERS HEALTHCARE MAKES NO REPRESENTATION OR WARRANTIES AS TO THE OPINIONS OR OTHER SERVICE OR DATA YOU MAY ACCESS, DOWNLOAD OR USE AS A RESULT OF USE OF THE THOMSON REUTERS HEALTHCARE PRODUCTS. ALL IMPLIED WARRANTIES OF MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE OR USE ARE HEREBY EXCLUDED. Thomson Reuters Healthcare does not assume any responsibility or risk for your use of the Thomson Reuters Healthcare products.
Zegren may be available in the countries listed below.
Diclofenac sodium salt (a derivative of Diclofenac) is reported as an ingredient of Zegren in the following countries:
International Drug Name Search
Nevigramon may be available in the countries listed below.
Nalidixic Acid is reported as an ingredient of Nevigramon in the following countries:
International Drug Name Search
Canovel Tapewormer may be available in the countries listed below.
In some countries, this medicine may only be approved for veterinary use.
Dichlorophen is reported as an ingredient of Canovel Tapewormer in the following countries:
International Drug Name Search
Moz-Bite may be available in the countries listed below.
Crotamiton is reported as an ingredient of Moz-Bite in the following countries:
International Drug Name Search
Mobalen may be available in the countries listed below.
Mexiletine hydrochloride (a derivative of Mexiletine) is reported as an ingredient of Mobalen in the following countries:
International Drug Name Search
B1-ASmedic may be available in the countries listed below.
Thiamine nitrate (a derivative of Thiamine) is reported as an ingredient of B1-ASmedic in the following countries:
International Drug Name Search
In the US, Alkeran (melphalan systemic) is a member of the drug class alkylating agents and is used to treat Multiple Myeloma and Ovarian Cancer.
US matches:
UK matches:
Melphalan is reported as an ingredient of Alkeran in the following countries:
Melphalan hydrochloride (a derivative of Melphalan) is reported as an ingredient of Alkeran in the following countries:
International Drug Name Search
Glossary
| SPC | Summary of Product Characteristics (UK) |
